Opioid-Related Disorders
19 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Brenipatide for opioid-related disorders | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cannabidiol + Dronabinol for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet + Naproxen 500 Mg + Opioids for opioid-related disorders | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Combined LAI Treatment: Cabenuva and Sublocade for opioid-related disorders | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Contingency management for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DBS of the NAc for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Deep Brain Simulator for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Diamorphine hydrochloride anhydrous for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DynamiCare Health for opioid-related disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ibogaine hydrochloride for opioid-related disorders | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Low-intensity focused ultrasound for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Low-Intensity Focused Ultrasound + Low-Intensity Focused Ultrasound - sham for opioid-related disorders | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Matching Intramuscular Placebo + IBOGAINE HYDROCHLORIDE for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| MDMA Assisted Therapy for opioid-related disorders | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psychotherapy for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psychotherapy + Medication for opioid use disorder for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters) for opioid-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Treatment with Ketone Supplement for opioid-related disorders | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Treatment with Placebo for opioid-related disorders | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |